Soleno Therapeutics GAAP EPS of $0.80 beats by $0.09, revenue of $91.73M beats by $3.18M

Soleno Therapeutics reported GAAP EPS of $0.80, beating estimates by $0.09, and revenue of $91.73 million, surpassing estimates by $3.18 million.